GET A QUOTE

Matrix Metalloproteinase-13 (MMP-13) ELISA Kit

  • Created on the 6 May, 2017.

BACKGROUND

Matrix metalloproteinase-13 which is more commonly referred to as collagenase 3, it is similar to the other MMPs and is secreted in an inactive pro-form which is activated upon being cleaved. The active enzyme consists of a catalytic domain and a hemopexin-like domain. Both the catalytic and hemopexin-like domain are require in order to preform efficient degradation of collagen. The MMP-13 is mainly expressed in the skeleton that is required for bone mineralization during embryonic development, however, it can also be highly over expressed in many pathological situations which can lead to human rheumatoid arthritis, osteoarthritis and carcinomas.

MMP13 expression in osteoarthritic cartilage along with its action against type II collagen, has led to the assumptions that this enzyme could plays a major role in cartilage collagen degradation. This makes it a complex target for a number of therapeutic interventions that are based on collagenase inhibition techniques. There is also evidence to indicate that it may also be responsible for articular cartilage turnover and cartilage pathophysiology which is linked to osteoarthritis.

INTENDED USE

Human MMP-13 ELISA kit is a procedure for determining in vitro quantitative concentrations of matrix metalloproteinase-13 (collagenase 3, MMP13) in human cell lysates, plasma, cell culture supernatant, other biological fluids and serum. This assay has a minimum sensitivity limit of 0.04 ng/ml.

SENSITIVITY

The minimum detection sensitivity level of human MMP-13 (collagenase 3) using this human matrix metalloproteinase-13 ELISA kit was 0.04 ng/ml. The dynamic assay range for this kit is 0.1 – 30 ng/ml.

REFERENCES

  1. Impact of matrix metalloproteinases on atherosclerosis. Curr Drug Targets. (2014) 15 (4): 442-53. Review. Lin J., et al.
  2. The structure, regulation, and function of human matrix metalloproteinase-13. Crit Rev Biochem Mol Biol. (2002) 37 (3): 149-66. Review. Leeman M.F., et al.
  3. New hope for the treatment of osteoarthritis through selective inhibition of MMP-13. Curr Med Chem. (2011) 18 (7): 977-1001. Review. Li N.G., et al.
  4. New strategies for targeting matrix metalloproteinases. Matrix Biol. (2015) 44-46: 239-46. Review. Fields G.B.
  5. Ten years in the life of an enzyme: the story of the human MMP-13 (collagenase-3). Mod Rheumatol. (2004) 14 (3): 197-204. Tardif G., et al.

ADDITIONAL INFORMATION

  • Full Name: Matrix Metalloproteinase-13 (MMP-13) ELISA Kit
  • Reactivity: Human
  • Sample Type: Other Biological Fluids, Serum, Cell Culture Supernatant, Plasma, Cell Lysates
  • Sensitivity: 0.04 ng/ml

OTHER RELATED ELISA KITS

TESTIMONIALS arrow icon

Your secretory IgA ELISA kit gave good results and I was also really impressed with how quickly we received it.

L. Johnston
PhD Student / University of Glasgow

It is refreshing to know that you have a technical team that is very knowledgeable. I have already recommended your company to other researchers in our department.

Dr. P. Anderson
Lecturer / University College London (UCL)

I am a first time user and found that your instruction manual was very easy to follow. The insulin ELISA kit performed well and I was happy with the results that were generated.

J. Thomas
Senior Technician / Addenbrooke’s Hospital

I carried out a pilot study comparing the performance of many ELISA kits from different suppliers and found your kits to be one of the better performers. We observed good linearity and tight replicates.

Dr. C. Davies
Lead Scientists / AstraZeneca

You are my first point of contact when I am looking to purchase ELISA kits. You have such an easy and simple system, yet it is very effective.

A. Shaw
Purchasing / University of Oxford